Status:
COMPLETED
Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
Lead Sponsor:
UCB Pharma
Conditions:
Epilepsy, Partial
Eligibility:
All Genders
18-45 years
Phase:
PHASE4
Brief Summary
Effect of adjunctive levetiracetam on polysomnography in adults with partial-onset epilepsy receiving a classical antiepileptic drug
Eligibility Criteria
Inclusion
- Subjects must have partial onset epilepsy and have been taking carbamazepine or phenytoin at a stable dose for a period of 4 weeks prior to the selection visit
- Subjects must have controlled partial onset seizures which can potentially benefit from adjunctive treatment
Exclusion
- Subjects dosing with LEV two weeks prior to the selection visit
- Subjects using more than one AED
- Subjects with specific and non-specific sleep disorders
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
November 1 2004
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00245713
Start Date
March 1 2003
End Date
November 1 2004
Last Update
November 26 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.